FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients

The U.S. Food and Drug Administration said on Tuesday it authorized Abbott Laboratories' glucose monitor, making it ​the first device that continuously monitors both ketone ‌levels and blood sugar.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。